IMAGO BIOSCIENCES
Imago BioSciences is a San Francisco-based clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives.
IMAGO BIOSCIENCES
Industry:
Biotechnology Life Science Medical
Founded:
2012-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.imagobio.com
Total Employee:
51+
Status:
Active
Contact:
(415) 529-5055
Email Addresses:
[email protected]
Total Funding:
146.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online Organization Schema
Similar Organizations
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Farallon Capital Management
Farallon Capital Management investment in Series C - Imago BioSciences
MRL Ventures Fund
MRL Ventures Fund investment in Series C - Imago BioSciences
Xeraya Capital
Xeraya Capital investment in Series C - Imago BioSciences
Greenspring Associates
Greenspring Associates investment in Series C - Imago BioSciences
Kingdon Capital
Kingdon Capital investment in Series C - Imago BioSciences
BlackRock
BlackRock investment in Series C - Imago BioSciences
Pharmaron
Pharmaron investment in Series C - Imago BioSciences
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Imago BioSciences
Amgen Ventures
Amgen Ventures investment in Series C - Imago BioSciences
Surveyor Capital
Surveyor Capital investment in Series C - Imago BioSciences
Key Employee Changes
Date | New article |
---|---|
2022-03-23 | Imago BioSciences Appoints Michael Arenberg to Chief Operating and Business Officer |
Official Site Inspections
http://www.imagobio.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.53 K
Unable to get host informations!!!